Healthcare provider profile · identity verified

Julia Faye Reon, MD

Family Practice · SUFFOLK, VA · NPI 1265407639

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	521	161
Atorvastatin Calcium	Atorvastatin Calcium	496	160
Omeprazole	Omeprazole	274	85
Gabapentin	Gabapentin	270	83
Losartan Potassium	Losartan Potassium	251	77
Levothyroxine Sodium	Levothyroxine Sodium	233	65
Albuterol Sulfate Hfa	Albuterol Sulfate	228	75
Hydrochlorothiazide	Hydrochlorothiazide	219	73
Metoprolol Succinate	Metoprolol Succinate	166	48
Furosemide	Furosemide	160	57
Rosuvastatin Calcium	Rosuvastatin Calcium	154	47
Metformin Hcl	Metformin Hcl	152	49
Lisinopril	Lisinopril	150	47
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	145	28
Eliquis	Apixaban	142	30
Tramadol Hcl	Tramadol Hcl	140	33
Potassium Chloride	Potassium Chloride	137	43
Montelukast Sodium	Montelukast Sodium	125	39
Simvastatin	Simvastatin	124	34
Carvedilol	Carvedilol	119	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	114	27
Pantoprazole Sodium	Pantoprazole Sodium	100	33
Meloxicam	Meloxicam	99	34
Tamsulosin Hcl	Tamsulosin Hcl	94	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	93	30
Fluticasone Propionate	Fluticasone Propionate	91	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	27
Zolpidem Tartrate	Zolpidem Tartrate	87	16
Alprazolam	Alprazolam	83	13
Duloxetine Hcl	Duloxetine Hcl	82	24
Lorazepam	Lorazepam	82	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	24
Trulicity	Dulaglutide	74	18
Nystatin	Nystatin	73	17
Metoprolol Tartrate	Metoprolol Tartrate	70	22
Pregabalin	Pregabalin	69	19
Famotidine	Famotidine	67	24
Glimepiride	Glimepiride	65	19
Pravastatin Sodium	Pravastatin Sodium	65	19
Ondansetron Odt	Ondansetron	59	19
Mirtazapine	Mirtazapine	57	17
Colchicine	Colchicine	56	15
Sertraline Hcl	Sertraline Hcl	55	19
Doxazosin Mesylate	Doxazosin Mesylate	54	18
Diclofenac Sodium	Diclofenac Sodium	52	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	14
Metformin Hcl Er	Metformin Hcl	50	16
Trazodone Hcl	Trazodone Hcl	50	16
Triamcinolone Acetonide	Triamcinolone Acetonide	50	34
Allopurinol	Allopurinol	49	17
Amitriptyline Hcl	Amitriptyline Hcl	49	14
Clopidogrel	Clopidogrel Bisulfate	49	18
Hydralazine Hcl	Hydralazine Hcl	49	17
Ozempic	Semaglutide	49	12
Celecoxib	Celecoxib	48	14
Ezetimibe	Ezetimibe	48	16
Jardiance	Empagliflozin	46	14
Hydroxyzine Hcl	Hydroxyzine Hcl	45	18
Ibuprofen	Ibuprofen	45	15
Valsartan	Valsartan	45	12
Ventolin Hfa	Albuterol Sulfate	45	11
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Donepezil Hcl	Donepezil Hcl	43	15
Tizanidine Hcl	Tizanidine Hcl	43	12
Atenolol	Atenolol	42	suppressed
Bumetanide	Bumetanide	41	12
Meclizine Hcl	Meclizine Hcl	40	19
Synthroid	Levothyroxine Sodium	40	12
Buspirone Hcl	Buspirone Hcl	39	13
Alendronate Sodium	Alendronate Sodium	38	11
Glipizide	Glipizide	38	14
Valacyclovir	Valacyclovir Hcl	37	15
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Spironolactone	Spironolactone	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	33	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	13
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Clonazepam	Clonazepam	30	suppressed
Baclofen	Baclofen	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Nitroglycerin	Nitroglycerin	29	16
Temazepam	Temazepam	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Fluconazole	Fluconazole	26	16
Lactulose	Lactulose	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Torsemide	Torsemide	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Ranolazine Er	Ranolazine	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Methylprednisolone	Methylprednisolone	22	14
Prednisone	Prednisone	22	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Ammonium Lactate	Ammonium Lactate	19	12
Benazepril Hcl	Benazepril Hcl	19	suppressed
Creon	Lipase/Protease/Amylase	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Amoxicillin	Amoxicillin	18	12
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Finasteride	Finasteride	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Azithromycin	Azithromycin	15	14
Estradiol	Estradiol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Metolazone	Metolazone	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Topiramate	Topiramate	14	suppressed
Cephalexin	Cephalexin	13	13
Colestipol Hcl	Colestipol Hcl	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Prasugrel Hcl	Prasugrel Hcl	13	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Linzess	Linaclotide	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error